A study of deep learning approaches for medication and adverse drug event extraction from clinical text

Natural Language Processing in medicine and ophthalmology: A review for the 21st-century clinician

Natural Language Processing (NLP) is a subfield of artificial intelligence that focuses on the interaction between computers and human language, enabling computers to understand, generate, and derive meaning from human language. NLP's potential applications in the medical field are extensive and vary from extracting data from Electronic Health Records -one of its most well-known and frequently exploited uses- to investigating relationships among genetics, biomarkers, drugs, and diseases for the proposal of new medications. NLP can be useful for clinical decision support, patient monitoring, or medical image analysis. Despite its vast potential, the real-world application of NLP is still limited due to various challenges and constraints, meaning that its evolution predominantly continues within the research domain. However, with the increasingly widespread use of NLP, particularly with the availability of large language models, such as ChatGPT, it is crucial for medical professionals to be aware of the status, uses, and limitations of these technologies.

Large Language Models and Genomics for Summarizing the Role of microRNA in Regulating mRNA Expression

microRNA (miRNA)-messenger RNA (mRNA or gene) interactions are pivotal in various biological processes, including the regulation of gene expression, cellular differentiation, proliferation, apoptosis, and development, as well as the maintenance of cellular homeostasis and pathogenesis of numerous diseases, such as cancer, cardiovascular diseases, neurological disorders, and metabolic conditions. Understanding the mechanisms of miRNA-mRNA interactions can provide insights into disease mechanisms and potential therapeutic targets. However, extracting these interactions efficiently from a huge collection of published articles in PubMed is challenging. In the current study, we annotated a miRNA-mRNA Interaction Corpus (MMIC) and used it for evaluating the performance of a variety of machine learning (ML) models, deep learning-based transformer (DLT) models, and large language models (LLMs) in extracting the miRNA-mRNA interactions mentioned in PubMed. We used the genomics approaches for validating the extracted miRNA-mRNA interactions. Among the ML, DLT, and LLM models, PubMedBERT showed the highest precision, recall, and F-score, with all equal to 0.783. Among the LLM models, the performance of Llama-2 is better when compared to others. Llama 2 achieved 0.56 precision, 0.86 recall, and 0.68 F-score in a zero-shot experiment and 0.56 precision, 0.87 recall, and 0.68 F-score in a three-shot experiment. Our study shows that Llama 2 achieves better recall than ML and DLT models and leaves space for further improvement in terms of precision and F-score.

Artificial intelligence-powered pharmacovigilance: A review of machine and deep learning in clinical text-based adverse drug event detection for benchmark datasets

OBJECTIVE

The primary objective of this review is to investigate the effectiveness of machine learning and deep learning methodologies in the context of extracting adverse drug events (ADEs) from clinical benchmark datasets. We conduct an in-depth analysis, aiming to compare the merits and drawbacks of both machine learning and deep learning techniques, particularly within the framework of named-entity recognition (NER) and relation classification (RC) tasks related to ADE extraction. Additionally, our focus extends to the examination of specific features and their impact on the overall performance of these methodologies. In a broader perspective, our research extends to ADE extraction from various sources, including biomedical literature, social media data, and drug labels, removing the limitation to exclusively machine learning or deep learning methods.

METHODS

We conducted an extensive literature review on PubMed using the query "(((machine learning [Medical Subject Headings (MeSH) Terms]) OR (deep learning [MeSH Terms])) AND (adverse drug event [MeSH Terms])) AND (extraction)", and supplemented this with a snowballing approach to review 275 references sourced from retrieved articles.

RESULTS

In our analysis, we included twelve articles for review. For the NER task, deep learning models outperformed machine learning models. In the RC task, gradient Boosting, multilayer perceptron and random forest models excelled. The Bidirectional Encoder Representations from Transformers (BERT) model consistently achieved the best performance in the end-to-end task. Future efforts in the end-to-end task should prioritize improving NER accuracy, especially for 'ADE' and 'Reason'.

CONCLUSION

These findings hold significant implications for advancing the field of ADE extraction and pharmacovigilance, ultimately contributing to improved drug safety monitoring and healthcare outcomes.

Extracting adverse drug events from clinical Notes: A systematic review of approaches used

BACKGROUND

An adverse drug event (ADE) is any unfavorable effect that occurs due to the use of a drug. Extracting ADEs from unstructured clinical notes is essential to biomedical text extraction research because it helps with pharmacovigilance and patient medication studies.

OBJECTIVE

From the considerable amount of clinical narrative text, natural language processing (NLP) researchers have developed methods for extracting ADEs and their related attributes. This work presents a systematic review of current methods.

METHODOLOGY

Two biomedical databases have been searched from June 2022 until December 2023 for relevant publications regarding this review, namely the databases PubMed and Medline. Similarly, we searched the multi-disciplinary databases IEEE Xplore, Scopus, ScienceDirect, and the ACL Anthology. We adopted the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement guidelines and recommendations for reporting systematic reviews in conducting this review. Initially, we obtained 5,537 articles from the search results from the various databases between 2015 and 2023. Based on predefined inclusion and exclusion criteria for article selection, 100 publications have undergone full-text review, of which we consider 82 for our analysis.

RESULTS

We determined the general pattern for extracting ADEs from clinical notes, with named entity recognition (NER) and relation extraction (RE) being the dual tasks considered. Researchers that tackled both NER and RE simultaneously have approached ADE extraction as a "pipeline extraction" problem (n = 22), as a "joint task extraction" problem (n = 7), and as a "multi-task learning" problem (n = 6), while others have tackled only NER (n = 27) or RE (n = 20). We further grouped the reviews based on the approaches for data extraction, namely rule-based (n = 8), machine learning (n = 11), deep learning (n = 32), comparison of two or more approaches (n = 11), hybrid (n = 12) and large language models (n = 8). The most used datasets are MADE 1.0, TAC 2017 and n2c2 2018.

CONCLUSION

Extracting ADEs is crucial, especially for pharmacovigilance studies and patient medications. This survey showcases advances in ADE extraction research, approaches, datasets, and state-of-the-art performance in them. Challenges and future research directions are highlighted. We hope this review will guide researchers in gaining background knowledge and developing more innovative ways to address the challenges.

Entity relationship extraction from Chinese electronic medical records based on feature augmentation and cascade binary tagging framework

Extracting entity relations from unstructured Chinese electronic medical records is an important task in medical information extraction. However, Chinese electronic medical records mostly have document-level volumes, and existing models are either unable to handle long text sequences or exhibit poor performance. This paper proposes a neural network based on feature augmentation and cascade binary tagging framework. First, we utilize a pre-trained model to tokenize the original text and obtain word embedding vectors. Second, the word vectors are fed into the feature augmentation network and fused with the original features and position features. Finally, the cascade binary tagging decoder generates the results. In the current work, we built a Chinese document-level electronic medical record dataset named VSCMeD, which contains 595 real electronic medical records from vascular surgery patients. The experimental results show that the model achieves a precision of 87.82% and recall of 88.47%. It is also verified on another Chinese medical dataset CMeIE-V2 that the model achieves a precision of 54.51% and recall of 48.63%.

Machine learning models to detect and predict patient safety events using electronic health records: A systematic review

INTRODUCTION

Identifying patient safety events using electronic health records (EHRs) and automated machine learning-based detection methods can help improve the efficiency and quality of healthcare service provision.

OBJECTIVE

This study aimed to systematically review machine learning-based methods and techniques, as well as their results for patient safety event management using EHRs.

METHODS

We reviewed the studies that focused on machine learning techniques, including automatic prediction and detection of patient safety events and medical errors through EHR analysis to manage patient safety events. The data were collected by searching Scopus, PubMed (Medline), Web of Science, EMBASE, and IEEE Xplore databases.

RESULTS

After screening, 41 papers were reviewed. Support vector machine (SVM), random forest, conditional random field (CRF), and bidirectional long short-term memory with conditional random field (BiLSTM-CRF) algorithms were mostly applied to predict, identify, and classify patient safety events using EHRs; however, they had different performances. BiLSTM-CRF was employed in most of the studies to extract and identify concepts, e.g., adverse drug events (ADEs) and adverse drug reactions (ADRs), as well as relationships between drug and severity, drug and ADEs, drug and ADRs. Recurrent neural networks (RNN) and BiLSTM-CRF had the best results in detecting ADEs compared to other patient safety events. Linear classifiers and Naive Bayes (NB) had the highest performance for ADR detection. Logistic regression had the best results in detecting surgical site infections. According to the findings, the quality of articles has non-significantly improved in recent years, but they had low average scores.

CONCLUSIONS

Machine learning can be useful in automatic detection and prediction of patient safety events. However, most of these algorithms have not yet been externally validated or prospectively tested. Therefore, further studies are required to improve the performance of these automated systems.

Named Entity Recognition in Electronic Health Records: A Methodological Review

OBJECTIVES

A substantial portion of the data contained in Electronic Health Records (EHR) is unstructured, often appearing as free text. This format restricts its potential utility in clinical decision-making. Named entity recognition (NER) methods address the challenge of extracting pertinent information from unstructured text. The aim of this study was to outline the current NER methods and trace their evolution from 2011 to 2022.

METHODS

We conducted a methodological literature review of NER methods, with a focus on distinguishing the classification models, the types of tagging systems, and the languages employed in various corpora.

RESULTS

Several methods have been documented for automatically extracting relevant information from EHRs using natural language processing techniques such as NER and relation extraction (RE). These methods can automatically extract concepts, events, attributes, and other data, as well as the relationships between them. Most NER studies conducted thus far have utilized corpora in English or Chinese. Additionally, the bidirectional encoder representation from transformers using the BIO tagging system architecture is the most frequently reported classification scheme. We discovered a limited number of papers on the implementation of NER or RE tasks in EHRs within a specific clinical domain.

CONCLUSIONS

EHRs play a pivotal role in gathering clinical information and could serve as the primary source for automated clinical decision support systems. However, the creation of new corpora from EHRs in specific clinical domains is essential to facilitate the swift development of NER and RE models applied to EHRs for use in clinical practice.

An End-to-End Natural Language Processing System for Automatically Extracting Radiation Therapy Events From Clinical Texts

PURPOSE

Real-world evidence for radiation therapy (RT) is limited because it is often documented only in the clinical narrative. We developed a natural language processing system for automated extraction of detailed RT events from text to support clinical phenotyping.

METHODS AND MATERIALS

A multi-institutional data set of 96 clinician notes, 129 North American Association of Central Cancer Registries cancer abstracts, and 270 RT prescriptions from HemOnc.org was used and divided into train, development, and test sets. Documents were annotated for RT events and associated properties: dose, fraction frequency, fraction number, date, treatment site, and boost. Named entity recognition models for properties were developed by fine-tuning BioClinicalBERT and RoBERTa transformer models. A multiclass RoBERTa-based relation extraction model was developed to link each dose mention with each property in the same event. Models were combined with symbolic rules to create a hybrid end-to-end pipeline for comprehensive RT event extraction.

RESULTS

Named entity recognition models were evaluated on the held-out test set with F1 results of 0.96, 0.88, 0.94, 0.88, 0.67, and 0.94 for dose, fraction frequency, fraction number, date, treatment site, and boost, respectively. The relation model achieved an average F1 of 0.86 when the input was gold-labeled entities. The end-to-end system F1 result was 0.81. The end-to-end system performed best on North American Association of Central Cancer Registries abstracts (average F1 0.90), which are mostly copy-paste content from clinician notes.

CONCLUSIONS

We developed methods and a hybrid end-to-end system for RT event extraction, which is the first natural language processing system for this task. This system provides proof-of-concept for real-world RT data collection for research and is promising for the potential of natural language processing methods to support clinical care.

Clinical named entity recognition and relation extraction using natural language processing of medical free text: A systematic review

BACKGROUND

Natural Language Processing (NLP) applications have developed over the past years in various fields including its application to clinical free text for named entity recognition and relation extraction. However, there has been rapid developments the last few years that there's currently no overview of it. Moreover, it is unclear how these models and tools have been translated into clinical practice. We aim to synthesize and review these developments.

METHODS

We reviewed literature from 2010 to date, searching PubMed, Scopus, the Association of Computational Linguistics (ACL), and Association of Computer Machinery (ACM) libraries for studies of NLP systems performing general-purpose (i.e., not disease- or treatment-specific) information extraction and relation extraction tasks in unstructured clinical text (e.g., discharge summaries).

RESULTS

We included in the review 94 studies with 30 studies published in the last three years. Machine learning methods were used in 68 studies, rule-based in 5 studies, and both in 22 studies. 63 studies focused on Named Entity Recognition, 13 on Relation Extraction and 18 performed both. The most frequently extracted entities were "problem", "test" and "treatment". 72 studies used public datasets and 22 studies used proprietary datasets alone. Only 14 studies defined clearly a clinical or information task to be addressed by the system and just three studies reported its use outside the experimental setting. Only 7 studies shared a pre-trained model and only 8 an available software tool.

DISCUSSION

Machine learning-based methods have dominated the NLP field on information extraction tasks. More recently, Transformer-based language models are taking the lead and showing the strongest performance. However, these developments are mostly based on a few datasets and generic annotations, with very few real-world use cases. This may raise questions about the generalizability of findings, translation into practice and highlights the need for robust clinical evaluation.

Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records

We assessed the generalizability of machine learning methods using natural language processing (NLP) techniques to detect adverse drug events (ADEs) from clinical narratives in electronic medical records (EMRs). We constructed a new corpus correlating drugs with adverse drug events using 1,394 clinical notes of 47 randomly selected patients who received immune checkpoint inhibitors (ICIs) from 2011 to 2018 at The Ohio State University James Cancer Hospital, annotating 189 drug-ADE relations in single sentences within the medical records. We also used data from Harvard's publicly available 2018 National Clinical Challenge (n2c2), which includes 505 discharge summaries with annotations of 1,355 single-sentence drug-ADE relations. We applied classical machine learning (support vector machine (SVM)), deep learning (convolutional neural network (CNN) and bidirectional long short-term memory (BiLSTM)), and state-of-the-art transformer-based (bidirectional encoder representations from transformers (BERT) and ClinicalBERT) methods trained and tested in the two different corpora and compared performance among them to detect drug-ADE relationships. ClinicalBERT detected drug-ADE relationships better than the other methods when trained using our dataset and tested in n2c2 (ClinicalBERT F-score, 0.78; other methods, F-scores, 0.61-0.73) and when trained using the n2c2 dataset and tested in ours (ClinicalBERT F-score, 0.74; other methods, F-scores, 0.55-0.72). Comparison among several machine learning methods demonstrated the superior performance and, therefore, the greatest generalizability of findings of ClinicalBERT for the detection of drug-ADE relations from clinical narratives in electronic medical records.

Hybrid approach combining deep learning and a rule based expert system for concept extraction from prescriptions

Concept extraction from prescriptions is a very important task that provides a foundation for many of the downstream healthcare applications in decision making across the areas of pharmacovigilance, medication adherence, inventory management, and other matters of value-based care. Although short, these directions can sometimes be complex. With the increase in complexity of direction, it becomes harder to extract various concepts by only rule based expert system. It identifies major concepts like frequency, dosage, duration, etc. from the natural text direction using a combination of rules and deep learning (DL) based methods on a large real world data of a pharmacy chain. The DL module includes a fine-tuned BERT transformer and Gram CNN (Convolutional Neural Network) based NER (Named Entity Recognition) architecture. The proposed method utilizes the domain heuristics along with intelligent labelling and bootstrapping to help DL models extract concepts with high evaluation scores and thus provides a way for carrying out concept extraction using targeted methods instead of one single method. To the best of our knowledge, this is the best performance reported in the literature for concept extraction from doctor's prescription.

Medication event extraction in clinical notes: Contribution of the WisPerMed team to the n2c2 2022 challenge

In this work, we describe the findings of the 'WisPerMed' team from their participation in Track 1 (Contextualized Medication Event Extraction) of the n2c2 2022 challenge. We tackle two tasks: (i) medication extraction, which involves extracting all mentions of medications from the clinical notes, and (ii) event classification, which involves classifying the medication mentions based on whether a change in the medication has been discussed. To address the long lengths of clinical texts, which often exceed the maximum token length that models based on the transformer-architecture can handle, various approaches, such as the use of ClinicalBERT with a sliding window approach and Longformer-based models, are employed. In addition, domain adaptation through masked language modeling and preprocessing steps such as sentence splitting are utilized to improve model performance. Since both tasks were treated as named entity recognition (NER) problems, a sanity check was performed in the second release to eliminate possible weaknesses in the medication detection itself. This check used the medication spans to remove false positive predictions and replace missed tokens with the highest softmax probability of the disposition types. The effectiveness of these approaches is evaluated through multiple submissions to the tasks, as well as with post-challenge results, with a focus on the DeBERTa v3 model and its disentangled attention mechanism. Results show that the DeBERTa v3 model performs well in both the NER task and the event classification task.

A deep learning approach for medication disposition and corresponding attributes extraction

OBJECTIVE

This article summarizes our approach to extracting medication and corresponding attributes from clinical notes, which is the focus of track 1 of the 2022 National Natural Language Processing (NLP) Clinical Challenges(n2c2) shared task.

METHODS

The dataset was prepared using Contextualized Medication Event Dataset (CMED), including 500 notes from 296 patients. Our system consisted of three components: medication named entity recognition (NER), event classification (EC), and context classification (CC). These three components were built using transformer models with slightly different architecture and input text engineering. A zero-shot learning solution for CC was also explored.

RESULTS

Our best performance systems achieved micro-average F1 scores of 0.973, 0.911, and 0.909 for the NER, EC, and CC, respectively.

CONCLUSION

In this study, we implemented a deep learning-based NLP system and demonstrated that our approach of (1) utilizing special tokens helps our model to distinguish multiple medications mentions in the same context; (2) aggregating multiple events of a single medication into multiple labels improves our model's performance.

Improving drug safety with adverse event detection using natural language processing

INTRODUCTION

Pharmacovigilance (PV) involves monitoring and aggregating adverse event information from a variety of data sources, including health records, biomedical literature, spontaneous adverse event reports, product labels, and patient-generated content like social media posts, but the most pertinent details in these sources are typically available in narrative free-text formats. Natural language processing (NLP) techniques can be used to extract clinically relevant information from PV texts to inform decision-making.

AREAS COVERED

We conducted a non-systematic literature review by querying the PubMed database to examine the uses of NLP in drug safety and distilled the findings to present our expert opinion on the topic.

EXPERT OPINION

New NLP techniques and approaches continue to be applied for drug safety use cases; however, systems that are fully deployed and in use in a clinical environment remain vanishingly rare. To see high-performing NLP techniques implemented in the real setting will require long-term engagement with end users and other stakeholders and revised workflows in fully formulated business plans for the targeted use cases. Additionally, we found little to no evidence of extracted information placed into standardized data models, which should be a way to make implementations more portable and adaptable.

Identifying stroke-related quantified evidence from electronic health records in real-world studies

BACKGROUND

Stroke is one of the leading causes of death and disability worldwide. The National Institutes of Health Stroke Scale (NIHSS) scores in electronic health records (EHRs), which quantitatively describe patients' neurological deficits in evidence-based treatment, are crucial in stroke-related clinical investigations. However, the free-text format and lack of standardization inhibit their effective use. Automatically extracting the scale scores from the clinical free text so that its potential value in real-world studies is realized has become an important goal.

OBJECTIVE

This study aims to develop an automated method to extract scale scores from the free text of EHRs.

METHODS

We propose a two-step pipeline method to identify NIHSS items and numerical scores and validate its feasibility using a freely accessible critical care database: MIMIC-III (Medical Information Mart for Intensive Care III). First, we utilize MIMIC-III to create an annotated corpus. Then, we investigate possible machine learning methods for two subtasks, NIHSS item and score recognition and item-score relation extraction. In the evaluation, we conduct both task-specific and end-to-end evaluations and compare our method with the rule-based method using precision, recall and F1 scores as evaluation metrics.

RESULTS

We use all available discharge summaries of stroke cases in MIMIC-III. The annotated NIHSS corpus contains 312 cases, 2929 scale items, 2774 scores and 2733 relations. The results show that the best F1-score of our method was 0.9006, which was attained by combining BERT-BiLSTM-CRF and Random Forest, and it outperformed the rule-based method (F1-score = 0.8098). In the end-to-end task, our method could successfully recognize the item "1b level of consciousness questions", the score "1" and their relation "('1b level of consciousness questions', '1', 'has value')" from the sentence "1b level of consciousness questions: said name = 1", while the rule-based method could not.

CONCLUSIONS

The two-step pipeline method we propose is an effective approach to identify NIHSS items, scores and their relations. With its help, clinical investigators can easily retrieve and access structured scale data, thereby supporting stroke-related real-world studies.

Contextualized medication information extraction using Transformer-based deep learning architectures

OBJECTIVE

To develop a natural language processing (NLP) system to extract medications and contextual information that help understand drug changes. This project is part of the 2022 n2c2 challenge.

MATERIALS AND METHODS

We developed NLP systems for medication mention extraction, event classification (indicating medication changes discussed or not), and context classification to classify medication changes context into 5 orthogonal dimensions related to drug changes. We explored 6 state-of-the-art pretrained transformer models for the three subtasks, including GatorTron, a large language model pretrained using > 90 billion words of text (including > 80 billion words from > 290 million clinical notes identified at the University of Florida Health). We evaluated our NLP systems using annotated data and evaluation scripts provided by the 2022 n2c2 organizers.

RESULTS

Our GatorTron models achieved the best F1-scores of 0.9828 for medication extraction (ranked 3rd), 0.9379 for event classification (ranked 2nd), and the best micro-average accuracy of 0.9126 for context classification. GatorTron outperformed existing transformer models pretrained using smaller general English text and clinical text corpora, indicating the advantage of large language models.

CONCLUSION

This study demonstrated the advantage of using large transformer models for contextual medication information extraction from clinical narratives.

Fine-tuning BERT for automatic ADME semantic labeling in FDA drug labeling to enhance product-specific guidance assessment

Product-specific guidances (PSGs) recommended by the United States Food and Drug Administration (FDA) are instrumental to promote and guide generic drug product development. To assess a PSG, the FDA assessor needs to take extensive time and effort to manually retrieve supportive drug information of absorption, distribution, metabolism, and excretion (ADME) from the reference listed drug labeling. In this work, we leveraged the state-of-the-art pre-trained language models to automatically label the ADME paragraphs in the pharmacokinetics section from the FDA-approved drug labeling to facilitate PSG assessment. We applied a transfer learning approach by fine-tuning the pre-trained Bidirectional Encoder Representations from Transformers (BERT) model to develop a novel application of ADME semantic labeling, which can automatically retrieve ADME paragraphs from drug labeling instead of manual work. We demonstrate that fine-tuning the pre-trained BERT model can outperform conventional machine learning techniques, achieving up to 12.5% absolute F1 improvement. To our knowledge, we were the first to successfully apply BERT to solve the ADME semantic labeling task. We further assessed the relative contribution of pre-training and fine-tuning to the overall performance of the BERT model in the ADME semantic labeling task using a series of analysis methods, such as attention similarity and layer-based ablations. Our analysis revealed that the information learned via fine-tuning is focused on task-specific knowledge in the top layers of the BERT, whereas the benefit from the pre-trained BERT model is from the bottom layers.

Predicting length of stay ranges by using novel deep neural networks

Background and aims

Accurately predicting length of stay (LOS) is considered a challenging task for health care systems globally. In previous studies on LOS range prediction, researchers commonly pre-classified the LOS ranges, which were the same for all patients in the same classification, and then utilized a classifier for prediction. In this study, we innovatively aimed to predict the specific LOS range for each patient (the LOS range was different for each patient).

Methods

In the modified deep neural network (DNN), the overall sample error (root mean square error (RMSE) method), the estimated sample error (ERR_pred method), the probability distribution with different loss functions (Dis_pred_Loss1, Dis_pred_Loss2, and Dis_pred_Loss3 method), and the generative adversarial networks (WGAN-GP for LOS method) are used for LOS range prediction. The Medical Information Mart for Intensive Care III (MIMIC-III) database is used to validate these methods.

Results

The RMSE method is convenient for LOS range prediction, but the predicted ranges are all consistent in the same batch of samples. The ERR_pred method can achieve better prediction results in samples with low errors. However, the prediction effect is worse in samples with larger errors. The Dis_pred_Loss1 method encounters a training instability problem. The Dis_pred_Loss2 and Dis_pred_Loss3 methods perform well in making predictions. Although WGAN-GP for LOS method does not show a substantial advantage over other methods, this method might have the potential to improve the predictive performance.

Conclusion

The results show that it is possible to achieve an acceptable accurate LOS range prediction through a reasonable model design, which may help physicians in the clinic.

Machine learning approaches for electronic health records phenotyping: a methodical review

OBJECTIVE

Accurate and rapid phenotyping is a prerequisite to leveraging electronic health records for biomedical research. While early phenotyping relied on rule-based algorithms curated by experts, machine learning (ML) approaches have emerged as an alternative to improve scalability across phenotypes and healthcare settings. This study evaluates ML-based phenotyping with respect to (1) the data sources used, (2) the phenotypes considered, (3) the methods applied, and (4) the reporting and evaluation methods used.

MATERIALS AND METHODS

We searched PubMed and Web of Science for articles published between 2018 and 2022. After screening 850 articles, we recorded 37 variables on 100 studies.

RESULTS

Most studies utilized data from a single institution and included information in clinical notes. Although chronic conditions were most commonly considered, ML also enabled the characterization of nuanced phenotypes such as social determinants of health. Supervised deep learning was the most popular ML paradigm, while semi-supervised and weakly supervised learning were applied to expedite algorithm development and unsupervised learning to facilitate phenotype discovery. ML approaches did not uniformly outperform rule-based algorithms, but deep learning offered a marginal improvement over traditional ML for many conditions.

DISCUSSION

Despite the progress in ML-based phenotyping, most articles focused on binary phenotypes and few articles evaluated external validity or used multi-institution data. Study settings were infrequently reported and analytic code was rarely released.

CONCLUSION

Continued research in ML-based phenotyping is warranted, with emphasis on characterizing nuanced phenotypes, establishing reporting and evaluation standards, and developing methods to accommodate misclassified phenotypes due to algorithm errors in downstream applications.

Adverse drug event detection using natural language processing: A scoping review of supervised learning methods

To reduce adverse drug events (ADEs), hospitals need a system to support them in monitoring ADE occurrence routinely, rapidly, and at scale. Natural language processing (NLP), a computerized approach to analyze text data, has shown promising results for the purpose of ADE detection in the context of pharmacovigilance. However, a detailed qualitative assessment and critical appraisal of NLP methods for ADE detection in the context of ADE monitoring in hospitals is lacking. Therefore, we have conducted a scoping review to close this knowledge gap, and to provide directions for future research and practice. We included articles where NLP was applied to detect ADEs in clinical narratives within electronic health records of inpatients. Quantitative and qualitative data items relating to NLP methods were extracted and critically appraised. Out of 1,065 articles screened for eligibility, 29 articles met the inclusion criteria. Most frequent tasks included named entity recognition (n = 17; 58.6%) and relation extraction/classification (n = 15; 51.7%). Clinical involvement was reported in nine studies (31%). Multiple NLP modelling approaches seem suitable, with Long Short Term Memory and Conditional Random Field methods most commonly used. Although reported overall performance of the systems was high, it provides an inflated impression given a steep drop in performance when predicting the ADE entity or ADE relation class. When annotating corpora, treating an ADE as a relation between a drug and non-drug entity seems the best practice. Future research should focus on semi-automated methods to reduce the manual annotation effort, and examine implementation of the NLP methods in practice.

Current status and trends in researches based on public intensive care databases: A scientometric investigation

Objective

Public intensive care databases cover a wide range of data that are produced in intensive care units (ICUs). Public intensive care databases draw great attention from researchers since they were time-saving and money-saving in obtaining data. This study aimed to explore the current status and trends of publications based on public intensive care databases.

Methods

Articles and reviews based on public intensive care databases, published from 2001 to 2021, were retrieved from the Web of Science Core Collection (WoSCC) for investigation. Scientometric software (CiteSpace and VOSviewer) were used to generate network maps and reveal hot spots of studies based on public intensive care databases.

Results

A total of 456 studies were collected. Zhang Zhongheng from Zhejiang University (China) and Leo Anthony Celi from Massachusetts Institute of Technology (MIT, USA) occupied important positions in studies based on public intensive care databases. Closer cooperation was observed between institutions in the same country. Six Research Topics were concluded through keyword analysis. Result of citation burst indicated that this field was in the stage of rapid development, with more diseases and clinical problems being investigated. Machine learning is still the hot research method in this field.

Conclusions

This is the first time that scientometrics has been used in the investigation of studies based on public intensive databases. Although more and more studies based on public intensive care databases were published, public intensive care databases may not be fully explored. Moreover, it could also help researchers directly perceive the current status and trends in this field. Public intensive care databases could be fully explored with more researchers' knowledge of this field.

A comparative study of pre-trained language models for named entity recognition in clinical trial eligibility criteria from multiple corpora

Background

Clinical trial protocols are the foundation for advancing medical sciences, however, the extraction of accurate and meaningful information from the original clinical trials is very challenging due to the complex and unstructured texts of such documents. Named entity recognition (NER) is a fundamental and necessary step to process and standardize the unstructured text in clinical trials using Natural Language Processing (NLP) techniques.

Methods

In this study we fine-tuned pre-trained language models to support the NER task on clinical trial eligibility criteria. We systematically investigated four pre-trained contextual embedding models for the biomedical domain (i.e., BioBERT, BlueBERT, PubMedBERT, and SciBERT) and two models for the open domains (BERT and SpanBERT), for NER tasks using three existing clinical trial eligibility criteria corpora. In addition, we also investigated the feasibility of data augmentation approaches and evaluated their performance.

Results

Our evaluation results using tenfold cross-validation show that domain-specific transformer models achieved better performance than the general transformer models, with the best performance obtained by the PubMedBERT model (F1-scores of 0.715, 0.836, and 0.622 for the three corpora respectively). The data augmentation results show that it is feasible to leverage additional corpora to improve NER performance.

Conclusions

Findings from this study not only demonstrate the importance of contextual embeddings trained from domain-specific corpora, but also shed lights on the benefits of leveraging multiple data sources for the challenging NER task in clinical trial eligibility criteria text.

Epidemiological challenges in pandemic coronavirus disease (COVID-19): Role of artificial intelligence

World is now experiencing a major health calamity due to the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus clade 2. The foremost challenge facing the scientific community is to explore the growth and transmission capability of the virus. Use of artificial intelligence (AI), such as deep learning, in (i) rapid disease detection from x-ray or computed tomography (CT) or high-resolution CT (HRCT) images, (ii) accurate prediction of the epidemic patterns and their saturation throughout the globe, (iii) forecasting the disease and psychological impact on the population from social networking data, and (iv) prediction of drug-protein interactions for repurposing the drugs, has attracted much attention. In the present study, we describe the role of various AI-based technologies for rapid and efficient detection from CT images complementing quantitative real-time polymerase chain reaction and immunodiagnostic assays. AI-based technologies to anticipate the current pandemic pattern, prevent the spread of disease, and face mask detection are also discussed. We inspect how the virus transmits depending on different factors. We investigate the deep learning technique to assess the affinity of the most probable drugs to treat COVID-19. This article is categorized under:Application Areas > Health CareAlgorithmic Development > Biological Data MiningTechnologies > Machine Learning.

Ensemble correction model for aspect-level sentiment classification

The aspect-level sentiment analysis is widely used in public opinion analysis. However, the problem of context information loss and distortion with the increase of the model depth is rarely considered in previous research. Few studies have attempted to combine the feature extracted from different embedding models. Based on the correction strategy, the ensemble correction (EC) model proposed in this study can correct context information loss and distortion. Based on the ensemble learning strategy and the weight sharing strategy, EC can extract features from different word embedding models and can reduce computational complexity. Experiments on the resturant14, laptop14, resturant16 and twitter datasets show that the accuracies of the EC model are 0.8848, 0.8213, 0.9301 and 0.7731, respectively. The accuracy of the EC model is higher than state-of-the-art models. Ablation studies and case studies are used to verify the model structure. The optimal number of graph convolutional network (GCN) layers is also verified.

CancerBERT: a cancer domain-specific language model for extracting breast cancer phenotypes from electronic health records

OBJECTIVE

Accurate extraction of breast cancer patients' phenotypes is important for clinical decision support and clinical research. This study developed and evaluated cancer domain pretrained CancerBERT models for extracting breast cancer phenotypes from clinical texts. We also investigated the effect of customized cancer-related vocabulary on the performance of CancerBERT models.

MATERIALS AND METHODS

A cancer-related corpus of breast cancer patients was extracted from the electronic health records of a local hospital. We annotated named entities in 200 pathology reports and 50 clinical notes for 8 cancer phenotypes for fine-tuning and evaluation. We kept pretraining the BlueBERT model on the cancer corpus with expanded vocabularies (using both term frequency-based and manually reviewed methods) to obtain CancerBERT models. The CancerBERT models were evaluated and compared with other baseline models on the cancer phenotype extraction task.

RESULTS

All CancerBERT models outperformed all other models on the cancer phenotyping NER task. Both CancerBERT models with customized vocabularies outperformed the CancerBERT with the original BERT vocabulary. The CancerBERT model with manually reviewed customized vocabulary achieved the best performance with macro F1 scores equal to 0.876 (95% CI, 0.873-0.879) and 0.904 (95% CI, 0.902-0.906) for exact match and lenient match, respectively.

CONCLUSIONS

The CancerBERT models were developed to extract the cancer phenotypes in clinical notes and pathology reports. The results validated that using customized vocabulary may further improve the performances of domain specific BERT models in clinical NLP tasks. The CancerBERT models developed in the study would further help clinical decision support.

Intelligent Telehealth in Pharmacovigilance: A Future Perspective

Pharmacovigilance improves patient safety by detecting and preventing adverse drug events. However, challenges exist that limit adverse drug event detection, resulting in many adverse drug events being underreported or inaccurately reported. One challenge includes having access to large data sets from various sources including electronic health records and wearable medical devices. Artificial intelligence, including machine learning methods, such as natural language processing and deep learning, can detect and extract information about adverse drug events, thus automating the pharmacovigilance process and improving the surveillance of known and documented adverse drug events. In addition, with the increased demand for telehealth services, for managing both acute and chronic diseases, artificial intelligence methods can play a role in detecting and preventing adverse drug events. In this review, we discuss two use cases of how artificial intelligence methods may be useful to improve the quality of pharmacovigilance and the role of artificial intelligence in telehealth practices.

Natural Language Processing Applications in the Clinical Neurosciences: A Machine Learning Augmented Systematic Review

Natural language processing (NLP), a domain of artificial intelligence (AI) that models human language, has been used in medicine to automate diagnostics, detect adverse events, support decision making and predict clinical outcomes. However, applications to the clinical neurosciences appear to be limited. NLP has matured with the implementation of deep transformer models (e.g., XLNet, BERT, T5, and RoBERTa) and transfer learning. The objectives of this study were to (1) systematically review NLP applications in the clinical neurosciences, and (2) explore NLP analysis to facilitate literature synthesis, providing clear examples to demonstrate the potential capabilities of these technologies for a clinical audience. Our NLP analysis consisted of keyword identification, text summarization and document classification. A total of 48 articles met inclusion criteria. NLP has been applied in the clinical neurosciences to facilitate literature synthesis, data extraction, patient identification, automated clinical reporting and outcome prediction. The number of publications applying NLP has increased rapidly over the past five years. Document classifiers trained to differentiate included and excluded articles demonstrated moderate performance (XLNet AUC = 0.66, BERT AUC = 0.59, RoBERTa AUC = 0.62). The T5 transformer model generated acceptable abstract summaries. The application of NLP has the potential to enhance research and practice in the clinical neurosciences.

From Tokenization to Self-Supervision: Building a High-Performance Information Extraction System for Chemical Reactions in Patents

Chemical reactions and experimental conditions are fundamental information for chemical research and pharmaceutical applications. However, the latest information of chemical reactions is usually embedded in the free text of patents. The rapidly accumulating chemical patents urge automatic tools based on natural language processing (NLP) techniques for efficient and accurate information extraction. This work describes the participation of the Melax Tech team in the CLEF 2020-ChEMU Task of Chemical Reaction Extraction from Patent. The task consisted of two subtasks: (1) named entity recognition to identify compounds and different semantic roles in the chemical reaction and (2) event extraction to identify event triggers of chemical reaction and their relations with the semantic roles recognized in subtask 1. To build an end-to-end system with high performance, multiple strategies tailored to chemical patents were applied and evaluated, ranging from optimizing the tokenization, pre-training patent language models based on self-supervision, to domain knowledge-based rules. Our hybrid approaches combining different strategies achieved state-of-the-art results in both subtasks, with the top-ranked F1 of 0.957 for entity recognition and the top-ranked F1 of 0.9536 for event extraction, indicating that the proposed approaches are promising.

Combining word embeddings to extract chemical and drug entities in biomedical literature

BACKGROUND

Natural language processing (NLP) and text mining technologies for the extraction and indexing of chemical and drug entities are key to improving the access and integration of information from unstructured data such as biomedical literature.

METHODS

In this paper we evaluate two important tasks in NLP: the named entity recognition (NER) and Entity indexing using the SNOMED-CT terminology. For this purpose, we propose a combination of word embeddings in order to improve the results obtained in the PharmaCoNER challenge.

RESULTS

For the NER task we present a neural network composed of BiLSTM with a CRF sequential layer where different word embeddings are combined as an input to the architecture. A hybrid method combining supervised and unsupervised models is used for the concept indexing task. In the supervised model, we use the training set to find previously trained concepts, and the unsupervised model is based on a 6-step architecture. This architecture uses a dictionary of synonyms and the Levenshtein distance to assign the correct SNOMED-CT code.

CONCLUSION

On the one hand, the combination of word embeddings helps to improve the recognition of chemicals and drugs in the biomedical literature. We achieved results of 91.41% for precision, 90.14% for recall, and 90.77% for F1-score using micro-averaging. On the other hand, our indexing system achieves a 92.67% F1-score, 92.44% for recall, and 92.91% for precision. With these results in a final ranking, we would be in the first position.

Ensemble of Deep Masked Language Models for Effective Named Entity Recognition in Health and Life Science Corpora

The health and life science domains are well known for their wealth of named entities found in large free text corpora, such as scientific literature and electronic health records. To unlock the value of such corpora, named entity recognition (NER) methods are proposed. Inspired by the success of transformer-based pretrained models for NER, we assess how individual and ensemble of deep masked language models perform across corpora of different health and life science domains-biology, chemistry, and medicine-available in different languages-English and French. Individual deep masked language models, pretrained on external corpora, are fined-tuned on task-specific domain and language corpora and ensembled using classical majority voting strategies. Experiments show statistically significant improvement of the ensemble models over an individual BERT-based baseline model, with an overall best performance of 77% macro F1-score. We further perform a detailed analysis of the ensemble results and show how their effectiveness changes according to entity properties, such as length, corpus frequency, and annotation consistency. The results suggest that the ensembles of deep masked language models are an effective strategy for tackling NER across corpora from the health and life science domains.

A contextual multi-task neural approach to medication and adverse events identification from clinical text

Effective wide-scale pharmacovigilance calls for accurate named entity recognition (NER) of medication entities such as drugs, dosages, reasons, and adverse drug events (ADE) from clinical text. The scarcity of adverse event annotations and underlying semantic ambiguities make accurate scope identification challenging. The current research explores integrating contextualized language models and multi-task learning from diverse clinical NER datasets to mitigate this challenge. We propose a novel multi-task adaptation method to refine the embeddings generated by the Bidirectional Encoder Representations from Transformers (BERT) language model to improve inter-task knowledge sharing. We integrated the adapted BERT model into a unique hierarchical multi-task neural network comprised of the medication and auxiliary clinical NER tasks. We validated the model using two different versions of BERT on diverse well-studied clinical tasks: Medication and ADE (n2c2 2018/n2c2 2009), Clinical Concepts (n2c2 2010/n2c2 2012), Disorders (ShAReCLEF 2013). Overall medication extraction performance enhanced by up to +1.19 F1 (n2c2 2018) while generalization enhanced by +5.38 F1 (n2c2 2009) as compared to standalone BERT baselines. ADE recognition enhanced significantly (McNemar's test), out-performing prior baselines. Similar benefits were observed on the auxiliary clinical and disorder tasks. We demonstrate that combining multi-dataset BERT adaptation and multi-task learning out-performs prior medication extraction methods without requiring additional features, newer training data, or ensembling. Taken together, the study contributes an initial case study towards integrating diverse clinical datasets in an end-to-end NER model for clinical decision support.

An attentive joint model with transformer-based weighted graph convolutional network for extracting adverse drug event relation

Adverse drug event (ADE) relation extraction is a crucial task for drug safety surveillance which aims to discover potential relations between ADE mentions from unstructured medical texts. To date, the graph convolutional networks (GCN) have been the state-of-the-art solutions for improving the ability of relation extraction task. However, there are many challenging issues that should be addressed. Among these, the syntactic information is not fully exploited by GCN-based methods, especially the diversified dependency edges. Still, these methods fail to effectively extract complex relations that include nested, discontinuous and overlapping mentions. Besides, the task is primarily regarded as a classification problem where each candidate relation is treated independently which neglects the interaction between other relations. To deal with these issues, in this paper, we propose an attentive joint model with transformer-based weighted GCN for extracting ADE Relations, called ADERel. Firstly, the ADERel system formulates the ADE relation extraction task as an N-level sequence labelling so as to model the complex relations in different levels and capture greater interaction between relations. Then, it exploits our neural joint model to process the N-level sequences jointly. The joint model leverages the contextual and structural information by adopting a shared representation that combines a bidirectional encoder representation from transformers (BERT) and our proposed weighted GCN (WGCN). The latter assigns a score to each dependency edge within a sentence so as to capture rich syntactic features and determine the most influential edges for extracting ADE relations. Finally, the system employs a multi-head attention to exchange boundary knowledge across levels. We evaluate ADERel on two benchmark datasets from TAC 2017 and n2c2 2018 shared tasks. The experimental results show that ADERel is superior in performance compared with several state-of-the-art methods. The results also demonstrate that incorporating a transformer model with WGCN makes the proposed system more effective for extracting various types of ADE relations. The evaluations further highlight that ADERel takes advantage of joint learning, showing its effectiveness in recognizing complex relations.

A natural language processing pipeline to synthesize patient-generated notes toward improving remote care and chronic disease management: a cystic fibrosis case study

Objectives

Patient-generated health data (PGHD) are important for tracking and monitoring out of clinic health events and supporting shared clinical decisions. Unstructured text as PGHD (eg, medical diary notes and transcriptions) may encapsulate rich information through narratives which can be critical to better understand a patient’s condition. We propose a natural language processing (NLP) supported data synthesis pipeline for unstructured PGHD, focusing on children with special healthcare needs (CSHCN), and demonstrate it with a case study on cystic fibrosis (CF).

Materials and Methods

The proposed unstructured data synthesis and information extraction pipeline extract a broad range of health information by combining rule-based approaches with pretrained deep-learning models. Particularly, we build upon the scispaCy biomedical model suite, leveraging its named entity recognition capabilities to identify and link clinically relevant entities to established ontologies such as Systematized Nomenclature of Medicine (SNOMED) and RXNORM. We then use scispaCy’s syntax (grammar) parsing tools to retrieve phrases associated with the entities in medication, dose, therapies, symptoms, bowel movements, and nutrition ontological categories. The pipeline is illustrated and tested with simulated CF patient notes.

Results

The proposed hybrid deep-learning rule-based approach can operate over a variety of natural language note types and allow customization for a given patient or cohort. Viable information was successfully extracted from simulated CF notes. This hybrid pipeline is robust to misspellings and varied word representations and can be tailored to accommodate the needs of a specific patient, cohort, or clinician.

Discussion

The NLP pipeline can extract predefined or ontology-based entities from free-text PGHD, aiming to facilitate remote care and improve chronic disease management. Our implementation makes use of open source models, allowing for this solution to be easily replicated and integrated in different health systems. Outside of the clinic, the use of the NLP pipeline may increase the amount of clinical data recorded by families of CSHCN and ease the process to identify health events from the notes. Similarly, care coordinators, nurses and clinicians would be able to track adherence with medications, identify symptoms, and effectively intervene to improve clinical care. Furthermore, visualization tools can be applied to digest the structured data produced by the pipeline in support of the decision-making process for a patient, caregiver, or provider.

Conclusion

Our study demonstrated that an NLP pipeline can be used to create an automated analysis and reporting mechanism for unstructured PGHD. Further studies are suggested with real-world data to assess pipeline performance and further implications.

Improving broad-coverage medical entity linking with semantic type prediction and large-scale datasets

OBJECTIVES

Biomedical natural language processing tools are increasingly being applied for broad-coverage information extraction-extracting medical information of all types in a scientific document or a clinical note. In such broad-coverage settings, linking mentions of medical concepts to standardized vocabularies requires choosing the best candidate concepts from large inventories covering dozens of types. This study presents a novel semantic type prediction module for biomedical NLP pipelines and two automatically-constructed, large-scale datasets with broad coverage of semantic types.

METHODS

We experiment with five off-the-shelf biomedical NLP toolkits on four benchmark datasets for medical information extraction from scientific literature and clinical notes. All toolkits adopt a staged approach of mention detection followed by two stages of medical entity linking: (1) generating a list of candidate concepts, and (2) picking the best concept among them. We introduce a semantic type prediction module to alleviate the problem of overgeneration of candidate concepts by filtering out irrelevant candidate concepts based on the predicted semantic type of a mention. We present MedType, a fully modular semantic type prediction model which we integrate into the existing NLP toolkits. To address the dearth of broad-coverage training data for medical information extraction, we further present WikiMed and PubMedDS, two large-scale datasets for medical entity linking.

RESULTS

Semantic type filtering improves medical entity linking performance across all toolkits and datasets, often by several percentage points of F-1. Further, pretraining MedType on our novel datasets achieves state-of-the-art performance for semantic type prediction in biomedical text.

CONCLUSIONS

Semantic type prediction is a key part of building accurate NLP pipelines for broad-coverage information extraction from biomedical text. We make our source code and novel datasets publicly available to foster reproducible research.

Application of Artificial Intelligence Methods to Pharmacy Data for Cancer Surveillance and Epidemiology Research: A Systematic Review

PURPOSE

The implementation and utilization of electronic health records is generating a large volume and variety of data, which are difficult to process using traditional techniques. However, these data could help answer important questions in cancer surveillance and epidemiology research. Artificial intelligence (AI) data processing methods are capable of evaluating large volumes of data, yet current literature on their use in this context of pharmacy informatics is not well characterized.

METHODS

A systematic literature review was conducted to evaluate relevant publications within four domains (cancer, pharmacy, AI methods, population science) across PubMed, EMBASE, Scopus, and the Cochrane Library and included all publications indexed between July 17, 2008, and December 31, 2018. The search returned 3,271 publications, which were evaluated for inclusion.

RESULTS

There were 36 studies that met criteria for full-text abstraction. Of those, only 45% specifically identified the pharmacy data source, and 55% specified drug agents or drug classes. Multiple AI methods were used; 25% used machine learning (ML), 67% used natural language processing (NLP), and 8% combined ML and NLP.

CONCLUSION

This review demonstrates that the application of AI data methods for pharmacy informatics and cancer epidemiology research is expanding. However, the data sources and representations are often missing, challenging study replicability. In addition, there is no consistent format for reporting results, and one of the preferred metrics, F-score, is often missing. There is a resultant need for greater transparency of original data sources and performance of AI methods with pharmacy data to improve the translation of these results into meaningful outcomes.

Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning

OBJECTIVE

Automated analysis of vaccine postmarketing surveillance narrative reports is important to understand the progression of rare but severe vaccine adverse events (AEs). This study implemented and evaluated state-of-the-art deep learning algorithms for named entity recognition to extract nervous system disorder-related events from vaccine safety reports.

MATERIALS AND METHODS

We collected Guillain-Barré syndrome (GBS) related influenza vaccine safety reports from the Vaccine Adverse Event Reporting System (VAERS) from 1990 to 2016. VAERS reports were selected and manually annotated with major entities related to nervous system disorders, including, investigation, nervous_AE, other_AE, procedure, social_circumstance, and temporal_expression. A variety of conventional machine learning and deep learning algorithms were then evaluated for the extraction of the above entities. We further pretrained domain-specific BERT (Bidirectional Encoder Representations from Transformers) using VAERS reports (VAERS BERT) and compared its performance with existing models.

RESULTS AND CONCLUSIONS

Ninety-one VAERS reports were annotated, resulting in 2512 entities. The corpus was made publicly available to promote community efforts on vaccine AEs identification. Deep learning-based methods (eg, bi-long short-term memory and BERT models) outperformed conventional machine learning-based methods (ie, conditional random fields with extensive features). The BioBERT large model achieved the highest exact match F-1 scores on nervous_AE, procedure, social_circumstance, and temporal_expression; while VAERS BERT large models achieved the highest exact match F-1 scores on investigation and other_AE. An ensemble of these 2 models achieved the highest exact match microaveraged F-1 score at 0.6802 and the second highest lenient match microaveraged F-1 score at 0.8078 among peer models.

A two-stage workflow to extract and harmonize drug mentions from clinical notes into observational databases

BACKGROUND

The content of the clinical notes that have been continuously collected along patients' health history has the potential to provide relevant information about treatments and diseases, and to increase the value of structured data available in Electronic Health Records (EHR) databases. EHR databases are currently being used in observational studies which lead to important findings in medical and biomedical sciences. However, the information present in clinical notes is not being used in those studies, since the computational analysis of this unstructured data is much complex in comparison to structured data.

METHODS

We propose a two-stage workflow for solving an existing gap in Extraction, Transformation and Loading (ETL) procedures regarding observational databases. The first stage of the workflow extracts prescriptions present in patient's clinical notes, while the second stage harmonises the extracted information into their standard definition and stores the resulting information in a common database schema used in observational studies.

RESULTS

We validated this methodology using two distinct data sets, in which the goal was to extract and store drug related information in a new Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) database. We analysed the performance of the used annotator as well as its limitations. Finally, we described some practical examples of how users can explore these datasets once migrated to OMOP CDM databases.

CONCLUSION

With this methodology, we were able to show a strategy for using the information extracted from the clinical notes in business intelligence tools, or for other applications such as data exploration through the use of SQL queries. Besides, the extracted information complements the data present in OMOP CDM databases which was not directly available in the EHR database.

COVID-19 SignSym: a fast adaptation of a general clinical NLP tool to identify and normalize COVID-19 signs and symptoms to OMOP common data model

The COVID-19 pandemic swept across the world rapidly, infecting millions of people. An efficient tool that can accurately recognize important clinical concepts of COVID-19 from free text in electronic health records (EHRs) will be valuable to accelerate COVID-19 clinical research. To this end, this study aims at adapting the existing CLAMP natural language processing tool to quickly build COVID-19 SignSym, which can extract COVID-19 signs/symptoms and their 8 attributes (body location, severity, temporal expression, subject, condition, uncertainty, negation, and course) from clinical text. The extracted information is also mapped to standard concepts in the Observational Medical Outcomes Partnership common data model. A hybrid approach of combining deep learning-based models, curated lexicons, and pattern-based rules was applied to quickly build the COVID-19 SignSym from CLAMP, with optimized performance. Our extensive evaluation using 3 external sites with clinical notes of COVID-19 patients, as well as the online medical dialogues of COVID-19, shows COVID-19 SignSym can achieve high performance across data sources. The workflow used for this study can be generalized to other use cases, where existing clinical natural language processing tools need to be customized for specific information needs within a short time. COVID-19 SignSym is freely accessible to the research community as a downloadable package (https://clamp.uth.edu/covid/nlp.php) and has been used by 16 healthcare organizations to support clinical research of COVID-19.

A Discrete Joint Model for Entity and Relation Extraction from Clinical Notes

Extracting clinical concepts and their relations from clinical narratives is one of the fundamental tasks in clinical natural language processing. Traditional solutions often separate this task into two subtasks with a pipeline architecture, which first recognize the named entities and then classify the relations between any possible entity pairs. The pipeline architecture, although widely used, has two limitations: 1) it suffers from error propagation from the recognition step to the classification step, 2) it cannot utilize the interactions between the two steps. To address the limitations, we investigated a discrete joint model based on structured perceptron and beam search to jointly perform named entity recognition (NER) and relation classification (RC) from clinical notes.

Extracting Drug Names and Associated Attributes From Discharge Summaries: Text Mining Study

Background

Drug prescriptions are often recorded in free-text clinical narratives; making this information available in a structured form is important to support many health-related tasks. Although several natural language processing (NLP) methods have been proposed to extract such information, many challenges remain.

Objective

This study evaluates the feasibility of using NLP and deep learning approaches for extracting and linking drug names and associated attributes identified in clinical free-text notes and presents an extensive error analysis of different methods. This study initiated with the participation in the 2018 National NLP Clinical Challenges (n2c2) shared task on adverse drug events and medication extraction.

Methods

The proposed system (DrugEx) consists of a named entity recognizer (NER) to identify drugs and associated attributes and a relation extraction (RE) method to identify the relations between them. For NER, we explored deep learning-based approaches (ie, bidirectional long-short term memory with conditional random fields [BiLSTM-CRFs]) with various embeddings (ie, word embedding, character embedding [CE], and semantic-feature embedding) to investigate how different embeddings influence the performance. A rule-based method was implemented for RE and compared with a context-aware long-short term memory (LSTM) model. The methods were trained and evaluated using the 2018 n2c2 shared task data.

Results

The experiments showed that the best model (BiLSTM-CRFs with pretrained word embeddings [PWE] and CE) achieved lenient micro F-scores of 0.921 for NER, 0.927 for RE, and 0.855 for the end-to-end system. NER, which relies on the pretrained word and semantic embeddings, performed better on most individual entity types, but NER with PWE and CE had the highest classification efficiency among the proposed approaches. Extracting relations using the rule-based method achieved higher accuracy than the context-aware LSTM for most relations. Interestingly, the LSTM model performed notably better in the reason-drug relations, the most challenging relation type.

Conclusions

The proposed end-to-end system achieved encouraging results and demonstrated the feasibility of using deep learning methods to extract medication information from free-text data.

Adverse drug events and medication relation extraction in electronic health records with ensemble deep learning methods

Objective

Identification of drugs, associated medication entities, and interactions among them are crucial to prevent unwanted effects of drug therapy, known as adverse drug events. This article describes our participation to the n2c2 shared-task in extracting relations between medication-related entities in electronic health records.

Materials and Methods

We proposed an ensemble approach for relation extraction and classification between drugs and medication-related entities. We incorporated state-of-the-art named-entity recognition (NER) models based on bidirectional long short-term memory (BiLSTM) networks and conditional random fields (CRF) for end-to-end extraction. We additionally developed separate models for intra- and inter-sentence relation extraction and combined them using an ensemble method. The intra-sentence models rely on bidirectional long short-term memory networks and attention mechanisms and are able to capture dependencies between multiple related pairs in the same sentence. For the inter-sentence relations, we adopted a neural architecture that utilizes the Transformer network to improve performance in longer sequences.

Results

Our team ranked third with a micro-averaged F1 score of 94.72% and 87.65% for relation and end-to-end relation extraction, respectively (Tracks 2 and 3). Our ensemble effectively takes advantages from our proposed models. Analysis of the reported results indicated that our proposed approach is more generalizable than the top-performing system, which employs additional training data- and corpus-driven processing techniques.

Conclusions

We proposed a relation extraction system to identify relations between drugs and medication-related entities. The proposed approach is independent of external syntactic tools. Analysis showed that by using latent Drug-Drug interactions we were able to significantly improve the performance of non–Drug-Drug pairs in EHRs.

Clinical notes as prognostic markers of mortality associated with diabetes mellitus following critical care: A retrospective cohort analysis using machine learning and unstructured big data

BACKGROUND

Clinical notes are ubiquitous resources offering potential value in optimizing critical care via data mining technologies.

OBJECTIVE

To determine the predictive value of clinical notes as prognostic markers of 1-year all-cause mortality among people with diabetes following critical care.

MATERIALS AND METHODS

Mortality of diabetes patients were predicted using three cohorts of clinical text in a critical care database, written by physicians (n = 45253), nurses (159027), and both (n = 204280). Natural language processing was used to pre-process text documents and LASSO-regularized logistic regression models were trained and tested. Confusion matrix metrics of each model were calculated and AUROC estimates between models were compared. All predictive words and corresponding coefficients were extracted. Outcome probability associated with each text document was estimated.

RESULTS

Models built on clinical text of physicians, nurses, and the combined cohort predicted mortality with AUROC of 0.996, 0.893, and 0.922, respectively. Predictive performance of the models significantly differed from one another whereas inter-rater reliability ranged from substantial to almost perfect across them. Number of predictive words with non-zero coefficients were 3994, 8159, and 10579, respectively, in the models of physicians, nurses, and the combined cohort. Physicians' and nursing notes, both individually and when combined, strongly predicted 1-year all-cause mortality among people with diabetes following critical care.

CONCLUSION

Clinical notes of physicians and nurses are strong and novel prognostic markers of diabetes-associated mortality in critical care, offering potentially generalizable and scalable applications. Clinical text-derived personalized risk estimates of prognostic outcomes such as mortality could be used to optimize patient care.

Automated Machine Learning for Healthcare and Clinical Notes Analysis

Machine learning (ML) has been slowly entering every aspect of our lives and its positive impact has been astonishing. To accelerate embedding ML in more applications and incorporating it in real-world scenarios, automated machine learning (AutoML) is emerging. The main purpose of AutoML is to provide seamless integration of ML in various industries, which will facilitate better outcomes in everyday tasks. In healthcare, AutoML has been already applied to easier settings with structured data such as tabular lab data. However, there is still a need for applying AutoML for interpreting medical text, which is being generated at a tremendous rate. For this to happen, a promising method is AutoML for clinical notes analysis, which is an unexplored research area representing a gap in ML research. The main objective of this paper is to fill this gap and provide a comprehensive survey and analytical study towards AutoML for clinical notes. To that end, we first introduce the AutoML technology and review its various tools and techniques. We then survey the literature of AutoML in the healthcare industry and discuss the developments specific to clinical settings, as well as those using general AutoML tools for healthcare applications. With this background, we then discuss challenges of working with clinical notes and highlight the benefits of developing AutoML for medical notes processing. Next, we survey relevant ML research for clinical notes and analyze the literature and the field of AutoML in the healthcare industry. Furthermore, we propose future research directions and shed light on the challenges and opportunities this emerging field holds. With this, we aim to assist the community with the implementation of an AutoML platform for medical notes, which if realized can revolutionize patient outcomes.

Extracting Family History of Patients From Clinical Narratives: Exploring an End-to-End Solution With Deep Learning Models

Background

Patients’ family history (FH) is a critical risk factor associated with numerous diseases. However, FH information is not well captured in the structured database but often documented in clinical narratives. Natural language processing (NLP) is the key technology to extract patients’ FH from clinical narratives. In 2019, the National NLP Clinical Challenge (n2c2) organized shared tasks to solicit NLP methods for FH information extraction.

Objective

This study presents our end-to-end FH extraction system developed during the 2019 n2c2 open shared task as well as the new transformer-based models that we developed after the challenge. We seek to develop a machine learning–based solution for FH information extraction without task-specific rules created by hand.

Methods

We developed deep learning–based systems for FH concept extraction and relation identification. We explored deep learning models including long short-term memory-conditional random fields and bidirectional encoder representations from transformers (BERT) as well as developed ensemble models using a majority voting strategy. To further optimize performance, we systematically compared 3 different strategies to use BERT output representations for relation identification.

Results

Our system was among the top-ranked systems (3 out of 21) in the challenge. Our best system achieved micro-averaged F1 scores of 0.7944 and 0.6544 for concept extraction and relation identification, respectively. After challenge, we further explored new transformer-based models and improved the performances of both subtasks to 0.8249 and 0.6775, respectively. For relation identification, our system achieved a performance comparable to the best system (0.6810) reported in the challenge.

Conclusions

This study demonstrated the feasibility of utilizing deep learning methods to extract FH information from clinical narratives.

Named Entity Recognition and Relation Detection for Biomedical Information Extraction

The number of scientific publications in the literature is steadily growing, containing our knowledge in the biomedical, health, and clinical sciences. Since there is currently no automatic archiving of the obtained results, much of this information remains buried in textual details not readily available for further usage or analysis. For this reason, natural language processing (NLP) and text mining methods are used for information extraction from such publications. In this paper, we review practices for Named Entity Recognition (NER) and Relation Detection (RD), allowing, e.g., to identify interactions between proteins and drugs or genes and diseases. This information can be integrated into networks to summarize large-scale details on a particular biomedical or clinical problem, which is then amenable for easy data management and further analysis. Furthermore, we survey novel deep learning methods that have recently been introduced for such tasks.

Medical Information Extraction in the Age of Deep Learning

OBJECTIVES

We survey recent developments in medical Information Extraction (IE) as reported in the literature from the past three years. Our focus is on the fundamental methodological paradigm shift from standard Machine Learning (ML) techniques to Deep Neural Networks (DNNs). We describe applications of this new paradigm concentrating on two basic IE tasks, named entity recognition and relation extraction, for two selected semantic classes-diseases and drugs (or medications)-and relations between them.

METHODS

For the time period from 2017 to early 2020, we searched for relevant publications from three major scientific communities: medicine and medical informatics, natural language processing, as well as neural networks and artificial intelligence.

RESULTS

In the past decade, the field of Natural Language Processing (NLP) has undergone a profound methodological shift from symbolic to distributed representations based on the paradigm of Deep Learning (DL). Meanwhile, this trend is, although with some delay, also reflected in the medical NLP community. In the reporting period, overwhelming experimental evidence has been gathered, as illustrated in this survey for medical IE, that DL-based approaches outperform non-DL ones by often large margins. Still, small-sized and access-limited corpora create intrinsic problems for data-greedy DL as do special linguistic phenomena of medical sublanguages that have to be overcome by adaptive learning strategies.

CONCLUSIONS

The paradigm shift from (feature-engineered) ML to DNNs changes the fundamental methodological rules of the game for medical NLP. This change is by no means restricted to medical IE but should also deeply influence other areas of medical informatics, either NLP- or non-NLP-based.